1. Home
  2. EVGO vs CADL Comparison

EVGO vs CADL Comparison

Compare EVGO & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVgo Inc.

EVGO

EVgo Inc.

HOLD

Current Price

$1.46

Market Cap

195.6M

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.87

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVGO
CADL
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
195.6M
1.0B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
EVGO
CADL
Price
$1.46
$10.87
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$5.23
$19.00
AVG Volume (30 Days)
3.3M
1.1M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
24.39
58.62
EPS
N/A
N/A
Revenue
$54,588,000.00
$125,000.00
Revenue This Year
$16.45
N/A
Revenue Next Year
$29.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
145.74
N/A
52 Week Low
$1.23
$4.35
52 Week High
$5.18
$14.00

Technical Indicators

Market Signals
Indicator
EVGO
CADL
Relative Strength Index (RSI) 50.22 41.77
Support Level $1.42 $9.40
Resistance Level $1.52 $11.36
Average True Range (ATR) 0.09 0.69
MACD 0.02 -0.28
Stochastic Oscillator 79.31 27.99

Price Performance

Historical Comparison
EVGO
CADL

About EVGO EVgo Inc.

EVgo Inc is an EV fast charging provider. The company deploys charging infrastructure by partnering with retailers, grocery stores, restaurants, gas stations, rideshare operators, and autonomous vehicle companies across the U.S., and serves the EV commercial segment by deploying fleet-charging solutions for light-duty EV fleets at depot locations, off-site charging hubs, or through its public network. It also owns PlugShare, a platform for EV drivers to locate public charging stations, plan trips and share charging experiences, which also provides charging location data licensing, infrastructure analysis, and EV driver research. It also derives revenue from the sale of regulatory credits earned from participation in LCFS programs and other carbon or emissions trading schemes in the U.S.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: